The Lancet Respiratory Medicine publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, and respiratory infections.
…
continue reading
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
…
continue reading
1
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
10:26
10:26
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:26
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ht…
…
continue reading
1
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
10:40
10:40
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:40
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM). Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://…
…
continue reading
1
In conversation with... Sergio Harari (in Italian)
10:40
10:40
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:40
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).Par The Lancet
…
continue reading
1
In conversation with... Sergio Harari
10:26
10:26
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:26
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).Par The Lancet
…
continue reading
1
In conversation with... Robert Kullberg
12:06
12:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:06
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.Par The Lancet
…
continue reading
1
Robert Kullberg on empirical antibiotics for Sepsis
12:06
12:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:06
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00257-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation …
…
continue reading
1
Heather Zar on early-life RSV disease and long-term respiratory health
19:07
19:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:07
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. You can read the Series of papers at: https://www.thelancet.com/series/respiratory-syncytial-virus?dgcid=buzzsprout_icw_pod…
…
continue reading
1
In conversation with... Heather Zar
19:07
19:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:07
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet.Par The Lancet
…
continue reading
1
In conversation with... Margaux Mesle
10:25
10:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:25
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications.Par The Lancet
…
continue reading
1
Margaux Mesle on lives saved by COVID-19 vaccination
10:21
10:21
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:21
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00179-6?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversat…
…
continue reading
1
In conversation with... James Hull
11:04
11:04
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:04
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.Par The Lancet
…
continue reading
1
James Hull on protecting the respiratory health of athletes
11:04
11:04
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:04
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00183-8?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us tod…
…
continue reading
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma.Par The Lancet
…
continue reading
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp…
…
continue reading
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.Par The Lancet
…
continue reading
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00008-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.co…
…
continue reading
1
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
10:23
10:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:23
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://face…
…
continue reading
1
In conversation with... Daniel Steinfort and Shankar Siva
10:23
10:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:23
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.Par The Lancet
…
continue reading
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.Par The Lancet
…
continue reading
1
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
8:16
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lan…
…
continue reading
1
In conversation with... Sarah Gorst and Tim Nicholson
15:32
15:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:32
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.Par The Lancet
…
continue reading
1
Sarah Gorst and Tim Nicholson on long COVID outcomes
15:32
15:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:32
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup ht…
…
continue reading
1
In conversation with... Betty Raman
12:02
12:02
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:02
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.Par The Lancet
…
continue reading
1
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
12:02
12:02
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:02
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://ins…
…
continue reading
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.Par The Lancet
…
continue reading
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com…
…
continue reading
1
In conversation with... James Chalmers
11:57
11:57
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:57
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.Par The Lancet
…
continue reading
1
James Chalmers on bronchiectasis across Europe
11:57
11:57
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:57
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_ep…
…
continue reading
1
In conversation with... Richard Costello
11:38
11:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:38
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.Par The Lancet
…
continue reading
1
Richard Costello on management of uncontrolled asthma
11:38
11:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:38
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company…
…
continue reading
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.Par The Lancet
…
continue reading
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Read the full article: Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial Continue this conver…
…
continue reading
1
In conversation with... Carol Hodgson
19:16
19:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:16
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.Par The Lancet
…
continue reading
1
Carol Hodgson on post-discharge outcomes for ECMO patients
19:16
19:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:16
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Read the full article: Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES) Co…
…
continue reading
1
In conversation with... Emma Grainger
13:06
13:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:06
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal.Par The Lancet
…
continue reading
1
Emma Grainger on 10 years of The Lancet Respiratory Medicine
13:06
13:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:06
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Read the Editorial from the 10th anniversary issue: Past learnings and new beginnings in the digital age Continue this conversation on social! Follow us today at... https://twitter.com/thelanc…
…
continue reading
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis.Par The Lancet
…
continue reading
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis. Read the full article: Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED) Continue this conversation on social! Follow us today at... https://…
…
continue reading
1
In conversation with... Yves Lacasse
17:15
17:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:15
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.Par The Lancet
…
continue reading
1
Yves Lacasse on long-term oxygen therapy for COPD
17:15
17:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:15
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD. Read the full article: Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis Continue this conversation on social! Follow us today at... https://t…
…
continue reading
1
Rachael Evans on living with long COVID
13:28
13:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:28
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study. Read the full article: Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelance…
…
continue reading
1
In conversation with... Rachael Evans
13:28
13:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:28
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.Par The Lancet
…
continue reading
1
In conversation with... Daniel Munblit and Dale Needham
16:37
16:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:37
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.Par The Lancet
…
continue reading
1
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
16:37
16:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:37
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition. Read the full Position Paper: A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study Continue this conversation on social! Follow us today at... htt…
…
continue reading
1
Daiana Stolz on antibiotic stewardship in pneumonia
10:16
10:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:16
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Read the full article: Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II) Continue t…
…
continue reading
1
In conversation with... Daiana Stolz
10:16
10:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:16
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection.Par The Lancet
…
continue reading
1
Ablo Wachinou on sleep disordered breathing in Benin
10:39
10:39
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:39
Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https:…
…
continue reading
1
In conversation with... Ablo Wachinou
10:39
10:39
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:39
Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.Par The Lancet
…
continue reading
1
In conversation with... Peter Openshaw and Felicity Liew
14:46
14:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:46
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.Par The Lancet
…
continue reading
1
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
14:46
14:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:46
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/the…
…
continue reading